The oxygen consumption rate (OCR) in HT-29 cells was measured in real-time using a XF-24 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) as previously reported [17]. For this, 3 × 104 cells were seeded for 16 h in the XF-24 plate and treated for 48 h on 0.5 mmol L−1 of FeNPs or VENOFER®. The medium was replaced with 450 μL/well of XF-24 running media (Seahorse Bioscience, Billerica, MA, USA), supplemented with 25 mmol L−1 glucose, 2 mmol L−1 glutamine, 1 mmol L−1 sodium pyruvate, without serum and pre-incubated at 37 °C for 20 min in the XF Prep Station incubator (Seahorse Bioscience, Billerica, MA, USA) in the absence of CO2. The plate was then transferred to the XF-24 Extracellular Flux Analyzer, and after an OCR baseline measurement, four sequential injections of compounds that affect bioenergetics were performed, as follows: 55 μL of oligomycin (1 μg mL−1), 61 μL of 2,4-Dinitrophenol (2,4 DNP) (1 mmol L−1), and 68 μL of antimycin A/rotenone (10 μmol L−1/1 μmol L−1) at injection in port C. Each treatment was carried out in three replicates and the final results were expressed as pmol of O2 consumed per 105 cells per minute (pmol O2/105 cells/min).
To evaluate glycolysis, extracellular acidification rate (ECAR) was measured in real-time using a XF-24 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) as previously reported [17]. ECAR was measured after addition of 55 μL of rotenone (1 μmol L−1), 61 μL of glucose (30 mmol L−1) and 68 μL 2-Deoxy-d-glucose (2-DG) (100 mmol L−1). Prior to measure ECAR, HT-29 cells were treated as in previous assay per triplicate and average ECAR value, expressed as milli-pH per minute (mpH/min) per 3.0 × 104 cells, was calculated for each treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.